Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CareRxFRA:29C1 66 Gross Margin % is 29.42% as of Jun. 2026, which is 1% above its 10-year median of 29.24. GuruFocus rates FRA:29C1 with a GF Score™ of 66/100 and a GF Value™ of €1.37. The stock has 3 warning signs investors should review. Among 629 Healthcare Providers & Services companies, CareRx ranks worse than 64.71% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. CareRx's Gross Profit for the
three
months ended in Jun. 2026 was €17.0 Mil. CareRx's Revenue for the
three
months ended in Jun. 2026 was €57.9 Mil. Therefore, CareRx's Gross Margin % for the quarter that ended in Jun. 2026 was 29.42%.
The historical rank and industry rank for CareRx's Gross Margin % or its related term are showing as below:
FRA:29C1'
s Gross Margin % Range Over the Past 10 Years
Min: 28.24 Med: 29.24 Max: 37.57
Current: 30.03
During the past 13 years, the highestGross Margin % of CareRx was 37.57%. The lowest was 28.24%. And the median was 29.24%.
FRA:29C1's Gross Margin % is ranked worse than 64.71% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs FRA:29C1: 30.03
CareRx had a gross margin of 29.42% for the quarter that ended in Jun. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for CareRx was 0.70% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
CareRx had a gross margin of 29.42% for the quarter that ended in Jun. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
CareRx Gross Margin % Related Terms
CareRx Gross Margin % Historical Data
* Premium members only.
The historical data trend for CareRx's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:29C1 vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, CareRx's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CareRx Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CareRx's Gross Margin % distribution charts can be found below:
* The bar in red indicates where CareRx's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
CareRx (FRA:29C1) has a Gross Margin % of 29.42% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on CareRx and its competitors. This is near median its historical median of 29.24. Over the past decade, CareRx's Gross Margin % has ranged from 28.24 to 37.57. According to the industry distribution chart, CareRx ranks #407 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 64.7%.
Is CareRx's Gross Margin % too high?
CareRx's current Gross Margin % of 29.42% is near median its 10-year median of 29.24. Over the past 10 years, this metric has ranged from a low of 28.24 to a high of 37.57. The Healthcare Providers & Services industry median Gross Margin % is 40.09. CareRx's value of 29.42% is 26.6% below this industry median. Based on the distribution chart, CareRx ranks #407 out of 629 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, CareRx has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does CareRx's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CareRx ranks #407 out of 629 companies for Gross Margin %. This places CareRx in the lower half of its industry. The industry median Gross Margin % is 40.09. CareRx's value of 29.42% is 26.6% below this benchmark. Historically, CareRx's own Gross Margin % has ranged from 28.24 to 37.57 over the past decade. While the company's 10-year median is 29.24 vs. the industry median of 40.09, CareRx has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CareRx's current Gross Margin % of 29.42% is 26.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on CareRx and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CareRx's current Gross Margin % is 29.42%, which is near median its own 10-year median of 29.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
CareRx (FRA:29C1) has a current Gross Margin % of 29.42%. The stock's GF Value™ is €1.37, compared to a current price of €2.04 — trading 48.9% above its estimated fair value. The current Gross Margin % is 29.42%, which is near median its 10-year median of 29.24 and 26.6% below the Healthcare Providers & Services industry median of 40.09. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For CareRx (FRA:29C1), the current Gross Margin % is 29.42% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CareRx (FRA:29C1) Overvalued in 2026?
Based on GuruFocus' analysis, CareRx stock appears to be overvalued.
The current stock price of €2.04 is trading 48.9% above its estimated GF Value™ of €1.37.
Key valuation signals for FRA:29C1:
Gross Margin %: 29.42% (near median its 10-year median of 29.24)
GF Value™: €1.37 vs. price of €2.04 (48.9% above fair value)
Industry Position: 26.6% below the Healthcare Providers & Services median (#407 of 629)
No single metric tells the full story. See the FRA:29C1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score
Get the complete analysis for FRA:29C1
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:29C1 has been successfully added to your 
